Free Trial

BioAtla (BCAB) Short Interest Ratio & Short Volume

BioAtla logo
$3.93 -0.12 (-2.96%)
Closing price 05/29/2026 04:00 PM Eastern
Extended Trading
$3.93 +0.00 (+0.03%)
As of 05/29/2026 07:25 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

BioAtla Short Interest Overview

As of May 15, 2026, BioAtla (BCAB) had a short interest of 162,567 shares sold short, representing 11.12% of the public float. This marks a 10.39% increase in short interest since the prior report. The short interest ratio (days to cover) is 5.5, meaning it would take 5.5 days of the average trading volume of 33,970 shares to cover all short positions.

Current Short Interest
162,567 shares
Previous Short Interest
147,268 shares
Change Vs. Previous Month
10.39%
Dollar Volume Sold Short
$694.16 thousand
Short Interest Ratio
5.5 Days to Cover
Last Record Date
May 15, 2026
Outstanding Shares
1,660,000 shares
Short Percent of Float
11.12%
Today's Trading Volume
33,656 shares
Average Trading Volume
33,970 shares
Today's Volume Vs. Average
99%
Short Selling BioAtla?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for BioAtla and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History

BCAB Short Interest Over Time

BCAB Days to Cover Over Time

BCAB Percentage of Float Shorted Over Time

BioAtla Tesla Short Interest History & Recent Changes

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/15/2026162,567 shares $694.16 thousand +10.4%11.1%5.49 $4.27
4/30/2026147,268 shares $620.00 thousand +30.0%10.1%3.65 $4.21
4/15/2026113,264 shares $510.82 thousand -95.2%7.7%1.65 $4.51
3/31/20262,365,733 shares $19.04 million +22.9%211.2%1.83 $8.05
3/13/20261,924,850 shares $317.79 thousand -5.9%3.4%1.28 $0.17
2/27/20262,045,751 shares $506.12 thousand -24.2%3.7%1.09 $0.25
2/13/20262,697,341 shares $404.60 thousand -59.2%4.8%0.68 $0.15
1/30/20266,612,587 shares $1.78 million +39.6%11.8%2.6 $0.27
1/15/20264,737,947 shares $1.51 million +9.8%8.5%1.87 $0.32
12/31/20254,316,860 shares $2.45 million -0.6%8.3%2.11 $0.57
12/15/20254,341,741 shares $3.35 million -29.9%8.4%4.39 $0.77
11/28/20256,190,599 shares $5.85 million +29.4%11.9%2.06 $0.95
11/14/20254,783,598 shares $3.78 million +5.8%9.2%4 $0.79
10/31/20254,521,208 shares $3.16 million +50.7%8.7%3.74 $0.70
10/15/20253,000,000 shares $2.49 million -29.9%5.8%3 $0.83
9/30/20254,280,000 shares $2.94 million -0.7%N/A4.9 $0.69
9/15/20254,310,000 shares $3.00 million +8.3%N/A5.5 $0.69
8/31/20253,980,000 shares $1.81 million -10.4%7.6%5.5 $0.46
8/15/20254,440,000 shares $1.63 million +13.3%N/A7.1 $0.37
7/31/20253,920,000 shares $1.41 million -7.8%7.6%6.6 $0.36
7/15/20254,250,000 shares $1.67 million +2.9%N/A6.8 $0.39
6/30/20254,130,000 shares $1.64 million +0.2%8.0%7.8 $0.40
6/15/20254,120,000 shares $1.67 million -2.8%8.0%7.3 $0.41
5/31/20254,240,000 shares $1.68 million -2.3%9.9%7.6 $0.40
5/15/20254,340,000 shares $1.86 million +0.9%10.1%7.1 $0.43
4/30/20254,300,000 shares $2.09 million +5.9%N/A5.9 $0.49
4/15/20254,060,000 shares $1.29 million -6.2%9.5%5.7 $0.32
3/31/20254,330,000 shares $1.50 million +2.6%10.1%5.2 $0.35
3/15/20254,220,000 shares $1.45 million +32.7%9.9%4 $0.34
2/28/20253,180,000 shares $1.04 million -17.0%7.4%2.9 $0.33
2/15/20253,830,000 shares $1.78 million -12.6%9.0%3.7 $0.46
1/31/20254,380,000 shares $2.06 million -13.4%N/A3.9 $0.47
1/15/20255,060,000 shares $2.44 million +15.0%N/A4.6 $0.48
12/31/20244,400,000 shares $2.60 million +11.4%N/A3.9 $0.59
12/15/20243,950,000 shares $5.73 million -0.8%N/A3 $1.45
11/30/20243,980,000 shares $6.69 million -3.9%N/A3.4 $1.68
11/15/20244,140,000 shares $6.46 million -15.0%N/A3.5 $1.56
10/31/20244,870,000 shares $9.35 million -7.1%N/A4 $1.92
10/15/20245,240,000 shares $10.22 million +17.2%N/A4.4 $1.95
9/30/20244,470,000 shares $7.87 million +0.5%N/A3.8 $1.76
Your book attached (Ad)

Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.tc pixel

Download the Safe Trade Options Formula book for free before access closes
9/15/20244,450,000 shares $8.05 million No ChangeN/A4.9 $1.81
8/31/20244,450,000 shares $7.88 million -6.3%N/A5 $1.77
8/15/20244,750,000 shares $8.93 million +18.8%N/A5 $1.88
7/31/20244,000,000 shares $7.24 million +0.5%N/A4.7 $1.81
7/15/20243,980,000 shares $6.97 million -24.2%N/A4.5 $1.75
6/30/20245,250,000 shares $7.19 million -3.3%N/A6.4 $1.37
6/15/20245,430,000 shares $8.63 million +0.6%N/A7 $1.59
5/31/20245,400,000 shares $8.15 million +3.9%N/A7.1 $1.51
5/15/20245,200,000 shares $15.60 million -2.4%N/A7.4 $3.00
4/30/20245,330,000 shares $12.02 million -1.7%N/A8.8 $2.26
4/15/20245,420,000 shares $15.50 million -3.0%N/A10.1 $2.86
3/31/20245,590,000 shares $19.23 million +9.0%N/A10.9 $3.44
3/15/20245,130,000 shares $12.52 million +0.4%N/A11.6 $2.44
2/29/20245,110,000 shares $13.80 million +1.4%N/A11 $2.70
2/15/20245,040,000 shares $13.36 million +6.6%N/A9.6 $2.65
1/31/20244,730,000 shares $9.06 million -3.3%N/A9.5 $1.92
1/15/20244,890,000 shares $11.78 million +4.7%N/A9.5 $2.41
12/31/20234,670,000 shares $11.49 million +4.7%N/A9.5 $2.46
12/15/20234,460,000 shares $9.41 million +0.2%N/A9.6 $2.11
11/30/20234,450,000 shares $7.88 million +8.0%N/A10.9 $1.77
11/15/20234,120,000 shares $6.63 million +1.0%N/A12.1 $1.61
10/31/20234,080,000 shares $6.00 million -7.3%N/A13.9 $1.47
10/15/20234,400,000 shares $7.26 million -5.2%N/A17.5 $1.65
9/30/20234,640,000 shares $7.89 million -6.8%N/A20.1 $1.70
9/15/20234,980,000 shares $10.36 million +2.1%N/A20.7 $2.08
8/31/20234,880,000 shares $12.25 million +3.2%N/A13.6 $2.51
8/15/20234,730,000 shares $12.91 million +1.9%N/A12.1 $2.73
7/31/20234,640,000 shares $13.87 million -1.1%N/A11.1 $2.99
7/15/20234,690,000 shares $12.66 million +1.5%N/A10.7 $2.70
6/30/20234,620,000 shares $13.86 million +25.9%N/A8.7 $3.00
6/15/20233,670,000 shares $13.73 million +1.7%N/A6.1 $3.74
5/31/20233,610,000 shares $11.37 million +0.6%N/A7.3 $3.15
5/15/20233,590,000 shares $13.89 million -5.0%N/A7.2 $3.87
4/30/20233,780,000 shares $12.74 million +16.7%N/A7.4 $3.37
4/15/20233,240,000 shares $11.66 million -10.3%N/A5.7 $3.60
3/31/20233,610,000 shares $9.67 million +10.4%N/A4.5 $2.68
3/15/20233,270,000 shares $8.37 million -0.6%N/A4.6 $2.56
2/28/20233,290,000 shares $9.80 million +13.8%N/A4.8 $2.98
2/15/20232,890,000 shares $9.88 million -0.3%N/A4.3 $3.42
1/31/20232,900,000 shares $10.99 million -10.8%N/A3.3 $3.79
1/15/20233,250,000 shares $11.25 million -21.9%N/A3.7 $3.46
12/30/20224,160,000 shares $34.32 million +2.2%N/A6.4 $8.25
12/15/20224,070,000 shares $36.51 million -5.1%N/A7.5 $8.97
11/30/20224,290,000 shares $47.23 million -3.6%N/A7.7 $11.01
11/15/20224,450,000 shares $39.16 million +10.2%N/A8 $8.80
10/31/20224,040,000 shares $27.84 million -20.6%N/A3.5 $6.89
10/15/20225,090,000 shares $35.07 million -1.0%N/A5.4 $6.89
9/30/20225,140,000 shares $39.58 million +27.5%N/A5.2 $7.70
9/15/20224,030,000 shares $34.46 million +7.8%N/A3.7 $8.55
8/31/20223,740,000 shares $32.58 million -32.9%N/A3.6 $8.71
SpaceX eyes a 1.75 trillion valuation - here's what to know (Ad)

Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a $1.75 trillion IPO - larger than Saudi Aramco and any tech offering in history. CNBC calls it 'the big market event of 2026.' According to former tech executive and angel investor Jeff Brown, there's a way to claim a stake before the public filing drops, starting with as little as $500.tc pixel

See how to get positioned in SpaceX before the announcement goes public
8/15/20225,570,000 shares $44.56 million +27.2%N/A5.2 $8.00
7/31/20224,380,000 shares $14.89 million -9.5%N/A7.7 $3.40
7/15/20224,840,000 shares $20.38 million +19.5%N/A7.9 $4.21
6/30/20224,050,000 shares $11.54 million +2.3%N/A6.5 $2.85
6/15/20223,960,000 shares $10.49 million -1.5%N/A5.8 $2.65
5/31/20224,020,000 shares $9.69 million +2.6%N/A5.5 $2.41
5/15/20223,920,000 shares $9.02 million +1.8%N/A5.3 $2.30
4/30/20223,850,000 shares $13.40 million +5.8%N/A5.2 $3.48
4/15/20223,640,000 shares $14.56 million +1.7%N/A5.1 $4.00
3/31/20223,580,000 shares $17.90 million -5.0%N/A5 $5.00
3/15/20223,770,000 shares $18.93 million -4.8%N/A6.2 $5.02
2/28/20223,960,000 shares $25.66 million -6.2%N/A7.8 $6.48
2/15/20224,220,000 shares $29.58 million +6.6%N/A8.8 $7.01
1/31/20223,960,000 shares $37.86 million +12.8%N/A9.6 $9.56
1/15/20223,510,000 shares $44.33 million +9.0%N/A10.5 $12.63
12/31/20213,220,000 shares $63.21 million +4.2%N/A12.7 $19.63
12/15/20213,090,000 shares $65.11 million +16.2%N/A15.1 $21.07
11/30/20212,660,000 shares $67.17 million +10.4%N/A11.7 $25.25
11/15/20212,410,000 shares $65.50 million -13.9%N/A10.8 $27.18
10/29/20212,800,000 shares $81.84 million No ChangeN/A12.5 $29.23
10/15/20212,800,000 shares $79.38 million -3.5%N/A11.9 $28.35
9/30/20212,900,000 shares $85.38 million +7.0%N/A12.4 $29.44
9/15/20212,710,000 shares $99.89 million -6.6%N/A11.3 $36.86
8/31/20212,900,000 shares $119.16 million -2.4%N/A11.3 $41.09
8/13/20212,970,000 shares $122.39 million -7.5%N/A13.6 $41.21
7/30/20213,210,000 shares $131.58 million -3.3%N/A15.4 $40.99
7/15/20213,320,000 shares $125.46 million +0.6%N/A17 $37.79
6/30/20213,300,000 shares $139.85 million +11.1%N/A16.6 $42.38
6/15/20212,970,000 shares $117.73 million +8.8%N/A15.8 $39.64

BCAB Short Interest - Frequently Asked Questions

Short interest is the volume of BioAtla shares that have been sold short but have not yet been covered or closed out. As of May 15th, investors have sold 162,567 shares of BCAB short. 11.12% of BioAtla's shares are currently sold short. Learn More on BioAtla's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BCAB shares currently have a short interest ratio of 5.5. Learn More on BioAtla's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 11.12% of BioAtla's floating shares are currently sold short.

BioAtla saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 162,567 shares, an increase of 10.4% from the previous total of 147,268 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

11.12% of BioAtla's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to BioAtla: Jasper Therapeutics, Inc. (9.31%), Sensei Biotherapeutics, Inc. (79.10%), Briacell Therap (6.53%), NextCure, Inc. (1.82%), TherapeuticsMD, Inc. (0.47%), Marker Therapeutics, Inc. (1.56%), Werewolf Therapeutics, Inc. (1.80%), Aytu BioPharma Inc. (4.49%), VYNE Therapeutics Inc. (0.38%), Novogen Limited (22.17%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($80.71 billion), Invesco QQQ ($47.96 billion), iShares Russell 2000 ETF ($22.13 billion), Western Digital Corporation ($14.35 billion), Sandisk Corporation ($12.86 billion), Salesforce Inc. ($10.89 billion), Nebius Group N.V. ($9.92 billion), SPDR S&P Biotech ETF ($9.72 billion), Lumentum Holdings Inc. ($8.89 billion), and iShares 20+ Year Treasury Bond ETF ($8.18 billion). View all of the most shorted stocks.

Short selling BCAB is an investing strategy that aims to generate trading profit from BioAtla as its price is falling. BCAB shares are trading down $0.12 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for BioAtla occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BCAB, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BCAB, twice per month. The most recent reporting period available is May, 15 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like BCAB:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.



This page (NASDAQ:BCAB) was last updated on 5/31/2026 by MarketBeat.com Staff.
From Our Partners